No profile data available.
Prenetics Global Limited (PRE) is a healthcare company in the medical testing laboratories industry, based in Quarry Bay, Hong Kong, with about 98 full-time employees.
It reported revenue of $92.39 million for fiscal year 2025, up 201.7% from fiscal year 2024, and net income of -$37.71 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $46.49 million, up 162.9% from a year before. Its largest business segment, Consumer Health, brought in 86% of segment revenue in fiscal year 2025; The United States was the largest region with 75%. Its market capitalization was $426.19 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand.
Prenetics Global reported $92.39 million in revenue for fiscal year 2025, up 201.7% from $30.62 million in fiscal year 2024. In Q2 2026 revenue was $46.49 million.
Consumer Health, with $79.45 million or 86% of segment revenue in fiscal year 2025. Next: Prevention (14%).
The United States: 75% of revenue by region in fiscal year 2025, followed by Hong Kong (25%).
$426.19 million as of October 9, 2026.
Listed companies of a similar size in the same industry (medical testing laboratories) include NeoGenomics, Inc. (NEO), Opko Health, Inc. (OPK), Fulgent Genetics, Inc. (FLGT), Biodesix, Inc. (BDSX).